0 CHECKOUT

PRODUCT FILTERS

REGION

68
26
19
18
18

COUNTRY

14
6
5
2
1

CATEGORIES

  • 31
  • 27
  • 21
  • 19
  • 14
  • 8
  • 7
  • 7
  • 6
  • 6
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

8
16
25
153

PUBLISHED

2
8
29
153

PRODUCT TYPE

146
4
2
1

Search for: "Strategic Analysis of Indian Biosimilar Market"

Global & USA BioSimilar Market Analysis to 2021

BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating Factor (G-CSF), Anti-Tumor Necrosis Factor (Anti-TNF), Monoclonal Antibodies (MAbs), Insulins, Interferons,...

Published:  August 2015
Price:  From

Global Biosimilars Industry 2015

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

Published:  February 2015
Price:  From

Global Oncology Biosimilars Market 2016-2020

About Oncology Biosimilars Cancer represents a huge burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of many cancer therapeutics enables the...

Published:  February 2016
Price:  From

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production Summary GBI Research,...

Published:  June 2012
Price:  From

World Biosimilars/Follow-on-Biologics Market - Opportunities and Forecasts, 2014 - 2020

Biosimilars or follow-on-biologics are highly similar versions of reference biologics derived from living organisms such as plants and animals. The development of biosimilars and validation with reference...

Published:  September 2015
Price:  From

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment Summary GBI Research, the leading business intelligence provider,...

Published:  April 2011
Price:  From

Biosimilars Market by Product (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application - Global Forecast to 2020.

Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application...

Published:  July 2015
Price:  From

Biosimilars - Global Strategic Business Report

This report analyzes the worldwide markets for Biosimilars in US$ Million The report provides separate comprehensive analytics for US, Europe, and Japan Annual estimates and forecasts are provided for...

Published:  April 2012
Price:  From

PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market Summary Our report, "PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars...

Published:  June 2014
Price:  From

Global Biosimilars Industry

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

Published:  October 2012
Price:  From

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary Our "PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers,...

Published:  May 2013
Price:  From

Generics/Biosimilars Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

Published:  November 2013
Price:  From

Global Biosimilars: A return to optimism?

A Critical Strategic Analysis from Espicom Despite some commentators predicting a muted or near nonexistent market for advanced biosimilars, many companies – and some surprising names – are positioning...

Published:  January 2012
Price:  From

Biosimilars (2009 - 2014)

The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities...

Published:  September 2009
Price:  From

Biosimilars in Emerging Markets

There are few areas of the pharmaceutical market more hotly debated than biosimilars yet the pathway to developing a viable global product marketplace is not clear Biosimilar interest is being driven...

Published:  March 2013
Price:  From

Human Insulin Market - Drugs, Types, Brands, Delivery Devices and Applications - Forecasts to 2020

"Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications...

Published:  January 2016
Price:  From

Human Growth Hormone Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Human Growth Hormone Drugs in US$ Million by the following Brands: Humatrope, Norditropin, Genotropin, Nutropin, Saizen, and Others. The report provides...

Published:  June 2014
Price:  From

Biosimilars and Biobetters: Positioning for a New Market

As regulatory frameworks for biosimilars development begin to take shape worldwide, there are growing opportunities for generics companies to enter the biologics market, a segment which is uniquely...

Published:  July 2009
Price: 

Emerging Markets Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

Published:  November 2013
Price:  From

Market Access Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

Published:  November 2013
Price:  From
Loading Indicator

Our Clients

  • NBC Universal Inc.
  • Samsung Electronics Co., Ltd.
  • E.ON SE
  • DHL International GmbH
  • University of Cambridge
  • Kone Oyj
  • BP Plc.